Medical Device Outsourcing Market (2025 - 2033)

Medical Device Outsourcing Market Summary

Regulatory approval procedures are becoming more stringent & time-consuming, and market players aim to receive product approvals on the first attempt to gain higher market share. Medical device companies have to manage continuous changes in regulatory requirements, which span over different business activities and multiple geographies worldwide. Noncompliance with changing regulatory requirements may result in penalties and delays, which may lead to loss of revenue. Geographic expansion by medical device companies aimed at speedy approvals in global markets is expected to further contribute to an increase in the adoption of outsourcing models for regulatory affairs services.

The medical device business is under continual pressure to regulate costs without compromising on the R&D process, time to market, or the associated safety & quality. Novel technologies, process developments, and a rapidly aging population are factors driving segment growth. As a result, regulations become increasingly stringent and complex due to heightened market competition. Medical device Original Equipment Manufacturers (OEMs) can benefit from increased agility, low operational costs, and reduced time to market, as well as high return on investment by outsourcing some of their operations. OEMs can also transform their companies into strategic investments from cost centers. Hence, this is expected to create demand for medical affairs outsourcing services.

Service Insights

On the basis of service, the market is classified into contract manufacturing services, quality assurance services, regulatory affairs services, product design & development services, product testing & sterilization services, product implementation services, product upgrade services, and product maintenance services. The contract manufacturing services segment accounted for the largest revenue share of 55.1% in 2024. Medical device market players are striving to reduce costs as profit margins are shrinking. To curtail fixed costs, companies are implementing shift work. In addition, small and medium-sized companies lack skilled labor and technical resources to complete the project. Contract manufacturing enables addressing the above-mentioned problems. Asia Pacific is considered the hub for contract manufacturing of the devices.

The quality assurance segment is anticipated to grow at the fastest CAGR during the forecast period. The segment growth is driven by the increasing emphasis on regulatory compliance, rising complexity of product development processes, and the growing need to maintain high standards of product safety and efficacy. In addition, the surge in outsourcing of quality assurance activities by pharmaceutical, biotechnology, and medical device companies to specialized service providers is further propelling segment expansion.

Application Insights

On the basis of application, the market is segregated into cardiology, diagnostic imaging, orthopedic, IVD, ophthalmic, general & plastic surgery, drug delivery, dental, endoscopy, diabetes care, and others. The cardiology segment held the largest share in 2024. The growth of the segment is due to the increasing prevalence of cardiovascular devices. Increasing incidences of conditions such as angina pectoris, myocardial infarction, hypertensive heart disease, rheumatic heart diseases, atrial fibrillation, and congenital heart disease are other vital drivers for the growth of this industry.

The general & plastic surgery segment is anticipated to grow at the fastest CAGR during the forecast period. The segment’s growth is due to the increasing demand for cosmetic surgeries, which is expected to boost the outsourcing of general as well as cosmetic surgical devices. Surgical devices such as fixation devices, extremity splint, and epilator require specialized molding and machining processes. These devices are usually outsourced to component manufacturers.

Class Type Insights

On the basis of class type, the market is segregated into Class I, Class II, and Class III. The Class II segment held the largest revenue share in the global market in 2024, owing to the high cost of medical devices, and almost 43% of medical devices fall under this category. Class II type includes catheters, syringes, surgical gloves, blood pressure cuffs, pregnancy test kits, contact lenses, and blood transfusion kits. These devices have a higher risk involved than Class I devices as they are to be in continuous contact with patients. This can include diagnostic tools and equipment that are always in contact with patient's internal organs or cardiovascular system.

The Class I segment is anticipated to grow at a considerable CAGR over the forecast period. These devices are noninvasive. Currently, 47% of the devices fall under this category, and 95% of the devices in this category are exempt from regulatory procedures due to a low risk level. Class I devices are easiest and fastest to purchase from the market due to a low amount of risk to the patient, and they rarely provide critical to life-sustaining care. The majority of Class I devices are exempt from the FDA's premarket notification (510k) and Premarket Approval Requirements (PMA).

Regional Insights

The Asia Pacific medical device outsourcing industry captured the largest market share of 40.98% in 2024. The regional growth is due to the presence of a large manufacturing base, lower labor costs, and the growing adoption of advanced medical technologies. In addition, strong government support for healthcare infrastructure, increasing demand for affordable medical devices, and the rising healthcare needs from a rapidly aging population in countries like China and India are significant drivers of the market.

The medical device outsourcing industry in China held the largest share in 2024. The growth is due to the country’s robust manufacturing infrastructure, increasing demand for effective and advanced therapies, and rising investments in advanced R&D for treatments. Moreover, supportive government initiatives, a large patient population, and the presence of cost-competitive contract manufacturers are also contributing to the country’s leading position in the regional market.

The Japan medical device outsourcing industry is expected to grow over the forecast period. The country’s growth is due to increasing focus on advanced drug delivery systems, rising prevalence of asthma and COPD, and strong collaboration between domestic medical device companies and specialized contract manufacturers. Japan’s well-established regulatory framework, high adoption of innovative technologies, and continuous investment in precision medicine further support the market’s expansion.

North America Medical Device Outsourcing Market Trends

The North America medical device outsourcing industry is projected to grow considerably due to the presence of numerous medical device companies, which are outsourcing parts of their regulatory and consulting functions to regulatory service providers. The high cost of R&D is a major challenge, which has encouraged various medical device companies in North America to outsource functions to third-party vendors with high levels of expertise in the domain.

U.S. Medical Device Outsourcing Market Trends

The medical device outsourcing industry in the U.S. held the largest share in 2024. The country’s growth is due presence of several medical device companies that are outsourcing parts of their regulatory functions, such as report writing & publishing, clinical trial application services, product design, and product maintenance, to regulatory service providers, thereby contributing to the growth of medical device outsourcing services. These companies are also increasingly inclined toward outsourcing due to the requirement of high maintenance and efficient systems for the management of raw materials, which results in minimizing the overall setup costs.

Europe Medical Device Outsourcing Market Trends

The medical device outsourcing industry in Europe is expected to grow significantly due to increasing investments in medical device R&D, the presence of advanced manufacturing infrastructure, and stringent regulatory standards, which are driving the demand for specialized contract manufacturing services.

The Germany medical device outsourcing industry held a significant share in 2024, owing to the country’s well-established medical device sector, strong focus on innovation, and advanced manufacturing infrastructure. Moreover, high R&D investments in respiratory therapies, coupled with strict regulatory standards for quality and safety, drive medical device companies to partner with experienced contract manufacturers.

The medical device outsourcing industry in the UK held the significant share in 2024. The growth of the market is due to the increasing demand for cost-effective manufacturing solutions, a robust regulatory environment ensuring quality and compliance, and the UK's strong innovation ecosystem, driving advanced medical device development and production.

Key Medical Device Outsourcing Company Insights

The major players operating across the market are focused on adopting inorganic strategic initiatives such as mergers, partnerships, acquisitions, etc. Moreover, companies focus on technological innovations to augment their market position.

Recent Developments

• In August 2025, IQVIA announced a strategic collaboration with Flagship Pioneering to accelerate life science company development, offering IQVIA’s analytics, information assets, and services from discovery through early development and commercialization.

Medical Device Outsourcing Market